Meiji Seika Pharma Co Ltd is categorized under Wholesale Pharmaceutical Products in Torrance, CA and active since 2012.
Meiji Seika Pharma Co Ltd was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Masahiko Matsuo at the company’s single location by writing to 21250 Hawthorne Boulevard, Torrance, California CA 90503 or by phoning (310) 792-7498. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Meiji Seika Pharma Co Ltd |
Contact Person: | Masahiko Matsuo |
Address: | 21250 Hawthorne Boulevard, Torrance, California 90503 |
Phone Number: | (310) 792-7498 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2012 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Wholesale Pharmaceutical Products |
SIC Code: | 5122 |
NAICS Code: | 424210 |
Share This Business: |
Meiji Seika Pharma Co Ltd was started in 2012 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Masahiko Matsuo for inquiries that concern Meiji Seika Pharma Co Ltd by calling the company number (310) 792-7498, as your correspondence is most welcome. Additionally, the physical location of the single location of Meiji Seika Pharma Co Ltd can be found at the coordinates 33.835949,-118.353081 as well as the street address 21250 Hawthorne Boulevard in Torrance, California 90503.
For its online presence, you may visit Meiji Seika Pharma Co Ltd’s website at and engage with its social media outlets through on Twitter and on Facebook.